🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

biote Corp.

BTMD Healthcare
$1.57 $-0.04 (-2.48%)
Market Cap: $53.22 M
Gurus Holding
3
Popularity Rank
#2882
% of Shares Held
1.46%
Net Activity (Q2 2026)
+$333,780.63

Guru Ownership Trend

Guru Analysis for biote Corp. (BTMD)

biote Corp. (BTMD), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $778,999.46.

Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).

Institutional sentiment is currently Bullish. This is evidenced by a $333,780.63 net inflow during the quarter.

Recent activity highlights Cliff Asness who increased their stake by 368.9%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 13.5%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$401,673.26
Total Buy Value
New Buys 1
Additions 1
-$67,892.63
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
2

FAQs for biote Corp. (BTMD)

Major holders include Cliff Asness ($475,561), Renaissance Technologies (RenTech) ($434,689), Steven Cohen ($27,528). According to the latest reported data, 3 tracked investment managers collectively hold approximately 496,178 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $333,780.63, with 2 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited BTMD. The total reported sell value was $67,892.63.

Yes, 1 managers opened new positions in BTMD, and 1 increased their existing holdings. The total reported buy value was $401,673.26.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Add 368.9% 251,619 $475,561 Q2 2026
0.00% Reduce -13.5% 229,994 $434,689 Q2 2026
0.00% New Buy 14,565 $27,528 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form